Kroger Closes Sale of Specialty Pharmacy Business

Retailer finalizes sale to Elevance Health

CINCINNATI, Oct. 4, 2024 /PRNewswire/ — The Kroger Co. (NYSE: KR) today announced the transaction to sell its specialty pharmacy business to Elevance Health has closed.

Kroger announced a definitive agreement with Elevance Health for the sale on March 18, 2024. In closing the transaction, the retailer and Elevance Health have worked to ensure minimal disruptions for patients and associates.

Kroger Family of Pharmacies in-store retail locations and The Little Clinics were not included in this transaction.

The specialty pharmacy, formerly owned by Kroger, serves patients with chronic illnesses that require complex care.

The sale is not expected to have an impact on 2024 guidance.

Advisors

RBC Capital Markets, LLC is serving as financial advisor and Weil, Gotshal & Manges LLP and Arnold & Porter Kaye Scholer LLP are serving as legal advisors to Kroger.

About Kroger

At The Kroger Co. (NYSE: KR), we are dedicated to our Purpose: To Feed the Human Spirit™. We are, across our family of companies nearly 420,000 associates who serve over 11 million customers daily through a seamless digital shopping experience and retail food stores under a variety of banner names, serving America through food inspiration and uplift, and creating #ZeroHungerZeroWaste communities. To learn more about us, visit our newsroom and investor relations site.

Forward Looking Statements

Statements in this release regarding the Company’s 2024 guidance, are forward-looking statements within the meaning of federal securities laws about the future performance of the Company. These statements are based on management’s assumptions and beliefs in light of the information currently available to it. Various uncertainties and other factors could cause actual results to differ materially from those contained in the forward-looking statements. These include the specific risk factors identified in “Risk Factors” in our annual report on Form 10-K for our last fiscal year and any subsequent filings. Kroger assumes no obligation to update the information contained herein unless required by applicable law. Please refer to Kroger’s reports and filings with the Securities and Exchange Commission for a further discussion of these risks and uncertainties.

View original content to download multimedia:https://www.prnewswire.com/news-releases/kroger-closes-sale-of-specialty-pharmacy-business-302267999.html